A real-world study of ustekinumab evaluating efficacy in refractory Crohn's disease patients
Latest Information Update: 13 Aug 2020
At a glance
- Drugs Ustekinumab (Primary) ; Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
- Acronyms CROHNUSK; LONG-CROHNUSK
Most Recent Events
- 08 Aug 2020 Results published in the Alimentary Pharmacology and Therapeutics
- 19 May 2020 Results published in Gasteroenterology in conjunction with Digestive Disease Week 2020
- 25 Jun 2019 New trial record